FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE
FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE · ONE OF JUST 8 NATIONWIDE
Explore More IV Treatments
NAD+ is the central coenzyme that powers mitochondrial ATP production, sirtuin activity (the longevity gene family), and PARP-mediated DNA repair. NAD+ levels decline measurably with age, chronic stress, alcohol use, and post-viral states like Long COVID — and that decline is now considered a primary driver of accelerated cellular aging.
Oral NAD+ precursors (NMN, NR) are absorbed inconsistently and require months of consistent dosing to meaningfully shift intracellular levels. IV NAD+ at 1,000 mg saturates the bloodstream directly and produces measurable shifts in cellular NAD+ within a single session. This is why TrufaMED's NAD+ protocol is delivered as a slow 3–4 hour infusion under continuous physician oversight — it is a clinical procedure, not a wellness drip.
Patients on structured longevity protocols — typically 4 to 6 NAD+ infusions over 4 to 6 weeks paired with HBOT and lifestyle optimization — report the most consistent gains in mental clarity, energy, and sleep architecture. Post-concussion patients often pair NAD+ with HBOT cognitive protocols. Addiction-recovery patients (alcohol, opioid) may receive NAD+ as part of a structured taper protocol coordinated with their addiction medicine physician.
NAD+ is infused slowly because faster delivery causes pronounced flushing, chest tightness, and nausea. Your physician calibrates the drip rate to your tolerance — most patients settle into a comfortable rhythm within the first 30 minutes. You can read, work, or rest during the infusion. Red Light Therapy is included free with every in-clinic NAD+ session.
NAD+ is the central coenzyme that powers mitochondrial ATP production, sirtuin activity (the longevity gene family), and PARP-mediated DNA repair. NAD+ levels decline measurably with age, chronic stress, alcohol use, and post-viral states like Long COVID — and that decline is now considered a primary driver of accelerated cellular aging.
Oral NAD+ precursors (NMN, NR) are absorbed inconsistently and require months of consistent dosing to meaningfully shift intracellular levels. IV NAD+ at 1,000 mg saturates the bloodstream directly and produces measurable shifts in cellular NAD+ within a single session. This is why TrufaMED's NAD+ protocol is delivered as a slow 3–4 hour infusion under continuous physician oversight — it is a clinical procedure, not a wellness drip.
Patients on structured longevity protocols — typically 4 to 6 NAD+ infusions over 4 to 6 weeks paired with HBOT and lifestyle optimization — report the most consistent gains in mental clarity, energy, and sleep architecture. Post-concussion patients often pair NAD+ with HBOT cognitive protocols. Addiction-recovery patients (alcohol, opioid) may receive NAD+ as part of a structured taper protocol coordinated with their addiction medicine physician.
NAD+ is infused slowly because faster delivery causes pronounced flushing, chest tightness, and nausea. Your physician calibrates the drip rate to your tolerance — most patients settle into a comfortable rhythm within the first 30 minutes. You can read, work, or rest during the infusion. Red Light Therapy is included free with every in-clinic NAD+ session.